ctrl K

Watchlist Price Alert

Silexion Therapeutics LTD (SLXN)

NASDAQ: SLXN · Real-Time Price · USD

0.98

-0.04 (-3.92%)

At close: May 06, 2025, 3:57 PM

1.03

4.79%

Pre-market: May 07, 2025, 06:41 AM EDT

Silexion Therapeutics LTD Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-1.9M	-8.04M	-1.39M	-1.25M	-1.73M	-731K	-155.47K	-808
Interest Income	n/a	n/a	6K	19K	33K	n/a	318K	n/a
Pretax Income	-1.75M	-11.86M	-1.49M	-1.42M	-1.67M	-803K	162.95K	-733
Net Income	-1.75M	-11.85M	-1.47M	-1.37M	-1.73M	-787K	162.95K	-774
Selling & General & Admin	1.04M	4.82M	612K	281K	465K	186K	155.47K	127.00
Research & Development	871K	3.22M	766K	961K	1.26M	535K	n/a	681.00
Other Expenses	-12K	n/a	7K	8K	6K	10K	n/a	n/a
Operating Expenses	1.9M	8.04M	1.39M	1.25M	1.73M	731K	155.47K	808.00
Interest Expense	n/a	n/a	2K	n/a	-43K	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	1.9M	8.04M	1.39M	1.25M	1.73M	731K	-155.47K	808.00
Income Tax Expense	1K	2K	2K	5K	6K	6K	n/a	10.00
Shares Outstanding (Basic)	1.85M	8.15M	8.15M	8.15M	8.15M	8.15M	660.51K	8.15M
Shares Outstanding (Diluted)	1.85M	8.15M	8.15M	8.15M	8.15M	8.15M	660.51K	8.15M
EPS (Basic)	-0.21	-1.45	-0.18	-0.17	-0.21	-0.1	0.25	-0.00
EPS (Diluted)	-0.21	-1.45	-0.18	-0.17	-0.21	-0.1	0.03	-0.00
EBITDA	-5.84M	-8.01M	-1.48M	-1.24M	-1.72M	-721K	162.95K	-793
EBIT	-5.83M	-8.04M	-1.49M	-1.25M	-1.73M	-731K	162.95K	-808
Depreciation & Amortization	-12K	22K	7K	8K	6K	10K	n/a	15.00